Maternal plasma prolactin levels in preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Reproductive Endocrinology
• Maternal-Fetal Medicine

Background:

• Preeclampsia is a serious pregnancy complication.
• Hormonal changes, including prolactin and estrogen, are implicated in pregnancy disorders.
• The role of prolactin in preeclampsia requires further clarification.

Purpose of the Study:

• To investigate the clinical significance of maternal plasma prolactin levels in preeclampsia.
• To examine the correlation between prolactin, estradiol-17 beta, and free estriol in normal and preeclamptic pregnancies.
• To assess the relationship between these hormones and fetal distress.

Main Methods:

• Maternal plasma levels of prolactin, estradiol-17 beta, and free estriol were measured.
• 118 normal pregnancies and 90 preeclamptic patients (35-40 weeks gestation) were studied.
• Statistical analysis was used to determine correlations and significance.

Main Results:

• Prolactin levels were similar in normal and preeclamptic pregnancies.
• Prolactin levels were not influenced by preeclampsia severity.
• A positive correlation was observed between free estriol and prolactin in preeclampsia.
• No correlation was found between prolactin and estradiol-17 beta or urinary estrogen.
• Fetal distress correlated with decreased estradiol, but not prolactin.

Conclusions:

• Maternal plasma prolactin estimation holds no clinical significance for diagnosing or managing preeclampsia.
• Free estriol levels show a mild correlation with prolactin in preeclamptic patients.
• Estradiol levels, not prolactin, may be indicative of fetal distress in preeclampsia.